Evidence map›Paper›PMID 28982981›Full record

ArticleThe Journal of biological chemistry2017

The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics.

Kristin Meliambro, Jenny S Wong, Justina Ray, Rhodora C Calizo, Sara Towne, Beatriz Cole, Fadi El Salem, Ronald E Gordon, Lewis Kaufman, John C He and 2 more

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Personalized disease recurrence modeling using iPSC-derived podocytes in patients with idiopathic nephrotic syndrome.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2025
    Article
  6. Article
  7. Article
  8. CRB2 depletion induces YAP signaling and disrupts mechanosensing in podocytes.American journal of physiology. Renal physiology · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. The role of dendrin in IgA nephropathy.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2023
    Article
  16. Article
  17. Article
  18. Review
  19. TAZ is important for maintenance of the integrity of podocytes.American journal of physiology. Renal physiology · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kristin MeliambroFrom the Division of Nephrology.
Jenny S WongFrom the Division of Nephrology.
Justina RayFrom the Division of Nephrology.
Rhodora C CalizoDepartment of Pharmacological Sciences, and.
Sara TowneDepartment of Pharmacological Sciences, and.
Beatriz ColeFrom the Division of Nephrology.
Fadi El SalemDepartment of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York 10029.
Ronald E GordonDepartment of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York 10029.
Lewis KaufmanFrom the Division of Nephrology.
John C HeFrom the Division of Nephrology.
Evren U AzelogluDepartment of Pharmacological Sciences, and.
Kirk N CampbellFrom the Division of Nephrology, kirk.campbell@mssm.edu.

Funding

The role of dendrin in glomerular disease progressionR01DK103022 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CAMPBELL, KIRK N · 2015 to 2019
$1.9M
NIDDK NIH HHS R01 DK103022
6 · The paper itself

Abstract

Kidney podocytes represent a key constituent of the glomerular filtration barrier. Identifying the molecular mechanisms of podocyte injury and survival is important for better understanding and management of kidney diseases. KIBRA (

Indexed as

Signal TransductionActin CytoskeletonAdaptor Proteins, Signal TransducingAnimalsBiopsyFemaleGene Expression RegulationGlomerulosclerosis, Focal SegmentalHEK293 CellsHippo Signaling PathwayHumansIntracellular Signaling Peptides and ProteinsMaleMice, Inbred C57BLMice, KnockoutMicroscopy, Electron, ScanningAdaptor Proteins, Signal TransducingIntracellular Signaling Peptides and ProteinsPhosphoproteinsProtein Serine-Threonine KinasesSerineTranscription FactorsWWC1 protein, humanYAP1 protein, humanYAP-Signaling Proteinsactinfocal adhesionHippo pathwaypodocyteyes-associated protein (YAP)

Identifiers

PMID28982981
PMCPMC5743086

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.